Decrease of antibiotic use after the introduction of time-limited prescription forms;Diminution de la consommation des antibiotiques apres introduction d'ordonnances nominatives a duree limitee

Medecine et Maladies Infectieuses

Volumn 29, Issue 9, 1999, Pages 567-572

  Alfandari, S ^a   Guery, B ^a   Senneville, E ^a   Georges, H ^a   Leroy, O ^a   George, O ^b   Coignard, C ^c   Caillaux, M ^c   Beaucaire, G ^a  

^a UNIV LILLE   (France)

^b Service de Pharmacie Hospitaliere   (France)

^c CENTRE HOSPITALIER DE TOURCOING   (France)

Author keywords

Antibiotic control; Multi drug resistance

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; FLUCONAZOLE; FOSFOMYCIN; FUSIDIC ACID; IMIPENEM; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; DRUG CONTROL; DRUG COST; DRUG USE; HEALTH CARE QUALITY; LENGTH OF STAY; MULTIDRUG RESISTANCE; PRESCRIPTION; UNIVERSITY HOSPITAL;

EID: 0033197527     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(00)80085-2     Document Type: Article

References (23)

1. Col NF, O'Connor RW. Estimating worldwide current antibiotic usage: Report of task force 1. Rev Infect Dis 1987; 9: 232-43.
2. Liss RH, Batchelor FR. Economic evaluations of antibiotic use and resistance - A perspective: Report of task force 6. Rev Infect Dis 1987; 9 Suppl 3: 297-312.
3. Andem, éd. Le bon usage des antibiotiques à l'hôpital. Recommandations Pour Maîtriser le Développement de la Résistance Bactérienne. Paris: NHA; 1997.
4. Anonymous. Control of antibiotic-resistant bacteria: Memorandum from a WHO meeting. World Health Organization scientific working group on antimicrobial resistance. Am J Hosp Pharm 1984; 41: 1329-37.
5. Shlaes DM, Gerding DN, John Jr JF, et al. Society for healthcare epidemiology of America and infectious diseases society of America joint committee on the prevention of antimicrobial resistance: Guidelines for the prevention of antimicrobial resistance in hospital. Clin Infect Dis 1997; 25: 584-99.
6. Working party of the British Society for Antimicrobial Chemotherapy. Hospital antibiotic control measures in the UK. J Antimicrob Chemother 1994; 34: 21-42.
7. Beaucaire G, éd. Le CAT. Utilisation rationnelle des antibiotiques à l'hôpital. Lille: Areclin: 1997.
8. Hekster YA, Vree TB, Goris RJ, Boerema JB. The defined daily dose per 100 bed-days as a unit of comparison and a parameter for studying antimicrobial drug use in a university hospital. A retrospective study of the effects of guidelines and audit on antimicrobial drug use. J Clin Hosp Pharm 1982; 7: 251-60.
9. Wertheimer AI. The defined daily dose system (DDD) for drug utilization review. Hosp Pharm 1986; 21: 233-58.
10. Carbon C. Antibiotic usage: Policy, clinical and pharmacoeconomic outcomes. Drugs 1996; 52 Suppl 2: 78-9.
11. McGowan JEJ. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994; 15: 478-83.
12. Jarvis WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: The complexity of the problem. Infect Control Hosp Epidemiol 1996; 17: 490-5.
13. Jones SR, Pannell J, Barks J, Yanchick YA, Bratton T, Browne R, et al. The effect of an educational program upon hospital antibiotic use. Am J Med Sci 1977; 273: 79-85.
14. Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JFJ, et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998; 338: 232-8.
15. Echols RM, Kowalsky SF. The use of an antibiotic order form for antibiotic utilization review: Influence on physicians prescribing patterns. J Infect Dis 1984; 150: 803-7.
16. White ACJ, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: Expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997; 25: 230-9.
17. Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance. Report of the national nosocomial resistance surveillance group. Diagn Microbiol Infect Dis 1992; 15: 37-42.
18. McGowan JEJ. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5: 1033-48.
19. Bamberger DM, Dahl SL. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital. Arch Intern Med 1992; 152: 554-7.
20. Young EJ, Sewell CM, Koza MA, Clarridge JE. Antibiotic resistance patterns during aminoglycoside restriction. Am J Med Sci 1985; 290: 223-7.
21. Pelletier LLJ. Hospital usage of parenteral antimicrobial agents: A gradated utilization review and cost containment program. Infect Control 1985; 6: 226-30.
22. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999; 96: 1152-6.
23. Causse R, Chouaid C, Callaert S, Le Paih MF, Cohen R, Thebault A. Impact d'une approche pluridisciplinaire pour la maîtrise de la prescription des antibiotiques dans un établissement hospitalier. Presse Med 1998; 27: 1371-5.